Premium
Neurogene Inc (NGNE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Samsara Biocapital, L.P. | Institution | 1 717 127 | 10,87% | US$ 55,43M | 2024-11-26 |
| Samsara BioCapital LLC | Institution | 1 717 127 | 10,87% | US$ 55,43M | 2026-03-31 |
| Redmile Group, LLC | Institution | 1 459 599 | 9,24% | US$ 47,12M | 2026-03-31 |
| Casdin Capital, LLC | Institution | 1 420 361 | 8,99% | US$ 45,85M | 2026-03-31 |
| RTW Investments, LP | Institution | 1 362 456 | 8,62% | US$ 43,98M | 2026-03-31 |
| EcoR1 Capital, LLC | Institution | 1 271 342 | 8,05% | US$ 41,04M | 2026-03-31 |
| Ecor1 Capital Fund Qualified, L.P. | Institution | 1 085 418 | 6,87% | US$ 35,04M | 2025-09-30 |
| BlackRock, Inc. | Institution | 1 005 070 | 6,36% | US$ 32,44M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 991 691 | 6,28% | US$ 32,01M | 2026-03-31 |
| Casdin Partners Master Fund, L.P. | Institution | 804 255 | 5,09% | US$ 25,96M | 2024-11-04 |
| Commodore Capital Master LP | Institution | 800 000 | 5,06% | US$ 25,82M | 2024-12-04 |
| Trails Edge Capital Partners, LP | Institution | 782 787 | 4,95% | US$ 25,27M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 718 389 | 4,55% | US$ 23,19M | 2026-03-31 |
| The Toronto-Dominion Bank | Institution | 681 337 | 4,31% | US$ 21,99M | 2026-03-31 |
| Redmile Biopharma Investments I | Institution | 652 030 | 4,13% | US$ 21,05M | 2025-12-31 |
| Biomedical Value Fund | Institution | 554 368 | 3,51% | US$ 17,89M | 2024-09-30 |
| Jennison Associates LLC | Institution | 527 685 | 3,34% | US$ 17,03M | 2026-03-31 |
| ArrowMark Colorado Holdings, LLC | Institution | 524 796 | 3,32% | US$ 16,94M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 514 727 | 3,26% | US$ 16,62M | 2026-03-31 |
| Great Point Partners, LLC | Institution | 500 000 | 3,16% | US$ 16,14M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 387 031 | 2,45% | US$ 12,49M | 2026-03-31 |
| FMR LLC | Institution | 382 447 | 2,42% | US$ 12,35M | 2026-03-31 |
| Biomedical Offshore Value Fund, LTD. | Institution | 381 631 | 2,42% | US$ 12,32M | 2024-09-30 |
| Norges Bank Investment Management | Institution | 367 412 | 2,33% | US$ 11,86M | 2025-12-31 |
| State Street Global Advisors, Inc. | Institution | 313 005 | 1,98% | US$ 10,10M | 2026-03-31 |
| Morgan Stanley | Institution | 283 492 | 1,79% | US$ 9,15M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 279 003 | 1,77% | US$ 9,01M | 2026-03-31 |
| Millennium Management LLC | Institution | 204 809 | 1,30% | US$ 6,61M | 2026-03-31 |
| UBS Asset Management AG | Institution | 185 971 | 1,18% | US$ 6,00M | 2026-03-31 |
| William Blair Investment Management, LLC | Institution | 168 218 | 1,06% | US$ 5,43M | 2026-03-31 |
| Deutsche Asset & Wealth Management | Institution | 106 255 | 0,67% | US$ 3,43M | 2026-03-31 |
| Rock Springs Capital Management LP | Institution | 104 339 | 0,66% | US$ 3,37M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 97 621 | 0,62% | US$ 3,15M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 93 642 | 0,59% | US$ 3,02M | 2026-03-31 |
| Woodline Partners LP | Institution | 83 835 | 0,53% | US$ 2,71M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 69 712 | 0,44% | US$ 2,25M | 2026-03-31 |
| Cheyne Capital Management (UK) LLP | Institution | 68 292 | 0,43% | US$ 2,20M | 2024-09-30 |
| Cheyne Global Equity Fund L.P. | Institution | 68 292 | 0,43% | US$ 2,20M | 2024-09-30 |
| Vanguard Portfolio Management, LLC | Institution | 65 080 | 0,41% | US$ 2,10M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
